LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer

Masoud Tavazoie(Rockefeller University), Ilana Pollack(Rockefeller University), Raissa Tanqueco(Rockefeller University), Benjamin N. Ostendorf(Rockefeller University), Bernardo Sgarbi Reis(Rockefeller University), Foster C. Gonsalves(RGenix (United States)), Isabel Kurth(RGenix (United States)), Celia Andreu-Agulló(RGenix (United States)), Mark L. Derbyshire(Rockefeller University), Jessica M. Posada(Rockefeller University), Shugaku Takeda(RGenix (United States)), Kimia N. Tafreshian(Rockefeller University), Eric K. Rowinsky(RGenix (United States)), Michael Szarek(SUNY Downstate Health Sciences University), Roger J. Waltzman(RGenix (United States)), Elizabeth A. McMillan(Rockefeller University), Connie Zhao(Rockefeller University), Monica Mita(Cedars-Sinai Medical Center), Alain C. Mita(Cedars-Sinai Medical Center), Bartosz Chmielowski(University of California, Los Angeles), Michael A. Postow(Memorial Sloan Kettering Cancer Center), Antoni Ribas(University of California, Los Angeles), Daniel Mucida(Rockefeller University), Sohail F. Tavazoie(Rockefeller University)
Cell
January 11, 2018
10.1016/j.cell.2017.12.026
Cited by 480Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis